HLNE logo

HLNE
Hamilton Lane Inc - Ordinary Shares - Class A

263
Mkt Cap
$4.94B
Volume
988,472.00
52W High
$179.19
52W Low
$82.69
PE Ratio
15.26
HLNE Fundamentals
Price
$90.32
Prev Close
$88.59
Open
$89.99
50D MA
$95.29
Beta
1.37
Avg. Volume
923,762.31
EPS (Annual)
$5.92
P/B
4.31
Rev/Employee
$966,870.06
$5,950.14
Loading...
Loading...
News
all
press releases
These Analysts Revise Their Forecasts On Hamilton Lane After Q4 Results
Hamilton Lane Inc (NASDAQ:HLNE) reported mixed Q4 results, beating earnings but missing sales estimates. Analysts lowered price targets.read more...
News Placeholder
More News
News Placeholder
Hamilton Lane (HLNE) Q4 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
Here's What Key Metrics Tell Us About Hamilton Lane (HLNE) Q4 Earnings
While the top- and bottom-line numbers for Hamilton Lane (HLNE) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
News Placeholder
Hamilton Lane Doubles Share Buyback Plan To $100 Mln
(RTTNews) - Hamilton Lane (HLNE) said on Thursday its board had approved an increase in its stock repurchase authorization to $100 million of Class A common stock...
News Placeholder
Hamilton Lane (HLNE) Beats Q4 Earnings Estimates
Hamilton Lane (HLNE) delivered earnings and revenue surprises of +4.20% and -3.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Hamilton Lane INC Q4 Sales Decline
(RTTNews) - Hamilton Lane INC (HLNE) revealed a profit for fourth quarter of $50.49 million...
News Placeholder
HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS
HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS PR Newswire CONSHOHOCKEN, Pa., May 21, 2026 CONSHOHOCKEN, Pa., May21, 2026 /PRNewswire/ -- Leading private markets asset management firm...
News Placeholder
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer (Brands). David joins the companys...
News Placeholder
Gear Up for Hamilton Lane (HLNE) Q4 Earnings: Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Hamilton Lane (HLNE) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
News Placeholder
Implied Volatility Surging for Hamilton Lane Stock Options
Investors need to pay close attention to HLNE stock based on the movements in the options market lately.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available